SGLT2 Inhibitors Produce Cardiorenal Benefits by Promoting Adaptive Cellular Reprogramming to Induce a State of Fasting Mimicry: A Paradigm Shift in Understanding Their Mechanism of Action
- PMID: 32079684
- DOI: 10.2337/dci19-0074
SGLT2 Inhibitors Produce Cardiorenal Benefits by Promoting Adaptive Cellular Reprogramming to Induce a State of Fasting Mimicry: A Paradigm Shift in Understanding Their Mechanism of Action
Comment in
-
Reinterpreting Cardiorenal Protection of Renal Sodium-Glucose Cotransporter 2 Inhibitors via Cellular Life History Programming.Diabetes Care. 2020 Mar;43(3):501-507. doi: 10.2337/dc19-1410. Epub 2019 Dec 16. Diabetes Care. 2020. PMID: 31843950
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
